Stoke Therapeutics (STOK) Earnings Date, Estimates & Call Transcripts $8.89 +0.14 (+1.55%) As of 02:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Stoke Therapeutics Earnings Summary Latest Q4 Earnings DateMar. 24EstimatedConsensus EPS (Mar. 24) -$0.56 Actual EPS (Mar. 24) -$0.18 Beat By $0.38 Actual Revenue (Mar. 24) $22.61MStoke Therapeutics released Q4 2024 earnings on March 24, 2025, reporting an EPS of -$0.18, which topped analysts' consensus estimates of -$0.56 by $0.38. Quarterly revenue was reported to be $22.61 million, above analyst estimates of $4.20 million. With a trailing EPS of -$1.68, Stoke Therapeutics' earnings are expected to decrease next year, from ($2.01) to ($2.27) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)Powered by Get Stoke Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Stoke Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSTOK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.STOK Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Stoke Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.57-$0.49-$0.53Q2 20252-$0.55-$0.54-$0.55Q3 20253-$0.67-$0.55-$0.61Q4 20253-$0.79-$0.56-$0.66 Stoke Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/24/2025Q4 2024-$0.56-$0.18+$0.38-$0.18$4.20M$22.61M11/5/2024--$0.52-$0.47+$0.05-$0.47$3.46M$4.89M8/7/2024--$0.57-$0.46+$0.11-$0.46$3.33M$4.83M5/6/2024Q1 2024-$0.60-$0.57+$0.03-$0.57$3.33M$4.22M3/25/2024Q4 2023-$0.62-$0.60+$0.02-$0.60$3.70M$2.80M11/7/2023Q3 2023-$0.65-$0.55+$0.10-$0.55$3.83M$3.31M8/7/2023Q2 2023-$0.63-$0.69 -$0.06-$0.69$4.00M-$2.48M Stoke Therapeutics Earnings - Frequently Asked Questions When did Stoke Therapeutics announce their last quarterly earnings? Stoke Therapeutics (NASDAQ:STOK) last announced its quarterly earning data on Monday, March 24, 2025. Learn more on STOK's earnings history. Did Stoke Therapeutics beat their earnings estimates last quarter? In the previous quarter, Stoke Therapeutics (NASDAQ:STOK) reported ($0.18) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.56) by $0.38. Learn more on analysts' earnings estimate vs. STOK's actual earnings. How much revenue does Stoke Therapeutics generate each year? Stoke Therapeutics (NASDAQ:STOK) has a recorded annual revenue of $36.56 million. How much profit does Stoke Therapeutics generate each year? Stoke Therapeutics (NASDAQ:STOK) has a recorded net income of -$104.70 million. STOK has generated -$1.68 earnings per share over the last four quarters. What is Stoke Therapeutics's EPS forecast for next year? Stoke Therapeutics's earnings are expected to decrease from ($2.01) per share to ($2.27) per share in the next year. More Earnings Resources from MarketBeat Related Companies Mirum Pharmaceuticals Earnings Date Bausch Health Companies Earnings Date Beam Therapeutics Earnings Date NewAmsterdam Pharma Earnings Date Vericel Earnings Date Belite Bio Earnings Date Tarsus Pharmaceuticals Earnings Date Janux Therapeutics Earnings Date Schrödinger Earnings Date Arrowhead Pharmaceuticals Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Stock Eyes Q1 Earnings After UAE UpdatesFord Motor Stock Rises After Earnings, But Momentum May Not Last Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx BoostPalantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's Earnings This page (NASDAQ:STOK) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredYour Wealth is Being Erased – Save It Before It’s Gone ForeverWhat If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands o...Hamilton Gold Group | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy STOK Stock Free STOK Stock Alerts